The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
ASCO Presents to NCI National Cancer Advisory Board
On September 16, Dr. Douglas Blayney (ASCO President) presented ASCO’s annual report to the National Cancer Institute’s National Cancer Advisory Board (NCAB). The NCAB serves in an advisory capacity to the Department of Health and Human Services and the NCI. ASCO Presidents have been delivering annual reports to the NCAB since 2006.
In his comments, Dr. Blayney highlighted the importance of NCI and the oncology research and treatment communities working together to advance the quality of cancer care through innovation. He related the importance of this effort given the national debate on health care reform in which policymakers are seeking ways to restrain health care costs and search for value in clinical care and research. He stressed that the field of oncology is very well poised to demonstrate value and improve quality. This positioning is due in part to federally funded clinical trials.
He challenged the NCAB to focus its efforts on four areas:
Enhance NCI support for clinical trials – His presentation included results from an ASCO poll of sites that participate in the Cooperative Group system. Forty percent of the 478 respondents indicated that they are planning or considering to limit their participation in NCI-funded trials. Seventy-five percent of the sites indicated that their plans to limit are due to NCI’s inadequate per-case reimbursement.
Explore and enhance innovative training partnerships – Dr. Blayney highlighted ASCO’s work in this area with online training, such as ASCO University.
Encourage efforts to harmonize federal regulatory requirements for research – Dr. Blayney discussed the array of requirements imposed by federal agencies and the work that ASCO is doing related to federal privacy rule requirements.
